anova with bonferroni post hoc test for multiple comparisons graphpad prism 8.0 software (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
anova with bonferroni post hoc test for multiple comparisons graphpad prism 8.0 software
Anova With Bonferroni Post Hoc Test For Multiple Comparisons Graphpad Prism 8.0 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/post-hoc+(bonferroni%E2%80%99s+multiple+comparison+test)/anova+followed+by+tukey%E2%80%99s+post+hoc+test/10__3390_slash_cimb47040215-124-22-23
Average 90 stars, based on 1 article reviews
Anova With Bonferroni Post Hoc Test For Multiple Comparisons Graphpad Prism 8.0 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/post-hoc+(bonferroni%E2%80%99s+multiple+comparison+test)/anova+followed+by+tukey%E2%80%99s+post+hoc+test/10__3390_slash_cimb47040215-124-22-23
Average 90 stars, based on 1 article reviews
anova with bonferroni post hoc test for multiple comparisons graphpad prism 8.0 software - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Comparison:Article Title: Analysis of sensitivity to MK-801 treatment in a novel active allothetic place avoidance task and in the working memory version of the Morris water maze reveals differences between Long-Evans and Wistar rats. Article Snippet: The aims of the present study were to compare the effect of subchronic administration of MK-801 on performance in the active allothetic place avoidance (AAPA) task and in the working version of Morris water maze (MWM) in Long-Evans and Wistar rats.. Animals were trained for four daily sessions either in the AAPA or in the working memory version of the MWM.. Wistar rats treated by MK-801 (0.1 mg/kg) showed a cognitive deficit in the AAPA task without a significant hyperlocomotion, whereas they were not impaired in the working memory version of the MWM compared to controls. |